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Wu et al Although inflammatory cells are frequently found in tumor biopsies, the relationship between cancer and the immune system has been increasingly recognized over the past 30 years. 5, 6 The neutrophil-to-lymphocyte ratio (NLR) measures the status of systemic inflammation and may be readily calculated from white blood cell counts. The NLR was reported to be an independent prognostic factor for patients with various types of cancer, and a high NLR was associated with adverse outcomes of lung, esophageal, gastric, colorectal, hepatic, and pancreatic cancers. [7] [8] [9] [10] [11] [12] Recent studies have also shown a negative prognostic value of higher NLR among patients with head and neck cancer. [13] [14] [15] [16] [17] [18] However, there are no studies on the prognostic value of NLR in early-stage (cT1/T2N0) tongue cancer. In addition, the need for elective neck dissection for clinical T1/T2N0 oral cancer was debatable in the past, despite possibly increasing survival rate. 19 Clinically, it would be worthwhile to study this issue because the inflammatory status and immune response may be different between advanced-stage tumors and early-stage tumors. Exploring the relationship between potential neck lymph node metastasis and NLR is also important in clinical practice. This study aims to identify the clinical significance of NLR and other clinicopathological variables in patients with early-stage (cT1/T2N0) tongue cancer.
Materials and methods Patients
Between January 2004 and December 2011, 262 patients with newly diagnosed cT1/T2N0 tongue squamous cell carcinoma who had undergone surgery as primary treatment at the Department of Otolaryngology, Kaohsiung Chang Gung Memorial Hospital, Taiwan, were enrolled retrospectively in this study from our cancer database. We excluded patients with chronic hepatitis or human immunodeficiency virus and those who had undergone immunotherapy and steroid or interferon treatment within 3 months before surgery. Information about preoperation hematologic parameters was collected. The NLR value was calculated by dividing the neutrophil count by the lymphocyte count. The T classification, N classification, and TNM stage were classified according to the 2010 AJCC system. The postoperative pathological data included TNM staging, tumor thickness, LND, lymphovascular invasion (LVI), perineural invasion (PNI), or extranodal extension of lymph node (ENE). The LND was calculated by dividing the number of involved lymph nodes of the disease by the total number of lymph nodes removed. The adjuvant therapy with radiation or chemoradiation of tongue cancer was based primarily on the guidelines of the National Comprehensive Cancer Network for oral cancer. Radiation dose was at least 6,000 cGy, and the chemotherapy was cisplatin based for adjuvant therapy. The study was approved by the Medical Ethics and Human Clinical Trial Committees at Chang Gung Memorial Hospital. Patients' consent to review their medical records was not required by these committees at this hospital because the patient data remained anonymous in this study.
statistical analyses
The optimal cutoff values of NLR and LND were determined using receiver operating characteristic curve analysis for survival prediction and then Youden's index equation for the specific value. Survival of prognostic factors was estimated using the Kaplan-Meier method, and the log-rank test determined the heterogeneity due to the specific factor. Cox proportional hazards model tested the independence of primary factors with other prognostic factors in multivariate survival modeling. All tests were two sided, and statistical significance was set at 0.05. All statistical analyses were carried out using the Statistical Package of Social Sciences software, version 20.0 (SPSS, Chicago, IL).
Results
Of the 262 patients, 87% (228) were male and 13% (34) were female; the median age of diagnosis for all was 51 years, ranging from 24 to 85 years. The mean follow-up was 67.1 months (from 2 to 137 months); 101 patients (38.5%) had a tumor thickness of ,5 mm, and the remaining 161 patients (61.5%) showed a tumor thickness of $5 mm. PNI was found in 48 patients (18.3%), LVI in 30 patients (11.5%), and ENE in 17 patients (6.5%). The mean NLR was 2.18 (range: 0.6-7.0), and the mean LND was 0.0197 (range: 0-0.546). At the end of the study, there were 57 (21.8%) patients who had died, and of these, 32 (12.2%) had died of tongue cancer. Local/regional failure occurred in 45 patients (17.2%). See Table 1 for the detailed baseline clinicopathological features of the 262 subjects and their survival outcomes.
The optimal cutoff value for NLR was 2.95, and that for LND was 0.031 ( Figure 1 ). Patients with NLR $2.95 correlated significantly with positive N classification (P=0.011), T2 classification (P=0.007), positive PNI (P,0.001), and tumor thickness of .5 mm (P=0.005; Table 2 ). The 5-year overall survival (OS) for patients with NLR ,2.95 was increased significantly compared with patients with NLR $2.95 (86% vs 57.6%, P,0.001; Figure 2A) Figure 2B ). Moreover, the 5-year DFS for patients with NLR ,2.95 was increased significantly compared with patients with NLR $2.95 (85.3% vs 67.7%, P=0.004; Figure 2C ).
Regarding the LND, the 5-year OS (54.2% vs 86.2%), DSS (60.7% vs 92.8%), and DFS (54.1% vs 87.8%) were also significantly reduced (all P,0.001, Figure 3 ) among patients with LND .0.031 compared with those with LND ,0.031. Other pathological factors, such as T2 classification, positive N classification, tumor thickness of $5 mm, positive PNI, and positive ENE, were all significant predictors of poor outcome for 5-year OS, DSS, and DFS (Table 3) .
Patients who were betel nut chewers showed significantly reduced 5-year OS (P=0.003) and DFS (P=0.009) compared with those without this habit. In addition, patients who were smokers showed significantly reduced 5-year OS (P=0.016) and DSS (P=0.035) compared with nonsmokers (Table 3) .
In multivariate analyses, NLR $2.95 was associated with reduced OS in early-stage (cT1/T2N0) tongue cancer (hazard ratio [HR]: 2.29, 95% CI: 1.32-3.96) and was adjusted by other independent factors, tumor thickness, and LND (Table 4 ). In the model, LND -another focusing prognostic factor in this study -had an HR of 2.57 (95% CI: 1.47-4.48) in LND $0.031 reference to LND ,0.031 for reduced OS (Table 4 
Discussion
In the current study of patients with early-stage (cT1/ T2N0) tongue cancer, we observed 5-year DFS, DSS, and OS rates of 82.8%, 87.8%, and 78.2%, respectively. Multivariate analysis indicated that OS was determined mainly by tumor thickness, LND, and NLR. In our study, tumor thickness with a cutoff value of 5 mm appears to be one of the significant prognostic factors related to 5-year OS and 5-year DFS. Many previous studies have shown that tumor thickness is a major predictive factor for neck lymph node metastasis and is correlated with survival or local recurrence. 20 The tumor thickness is also found to be an independent predictor of the 5-year DSS in tonsillar cancer. 21 Noninvasive tools for evaluating tumor thickness by MRI 22 and ultrasound 23 have proven to reliably identify patients who are likely to have a worse clinical outcome at the time of diagnosis.
Currently, the presence of neck metastasis and extranodal extension of lymph nodes remain the most significant predictors of prognosis in oral cancer. 24, 25 Recent studies have shown that traditional clinical nodal staging alone may not reliably predict prognosis or direct treatment in patients with primary squamous cell carcinoma of the tongue. 26 The concept of surgical staging with regard to nodal disease is a critical strategy for a range of malignancies, 27 taking into account both the extent of surgical clearance and the true nodal disease burden. This forms the basis of LND as an Table 7) . [28] [29] [30] [31] [32] [33] [34] [35] However, no study until now has explored early-stage (cT1/T2N0) tongue cancer, which is frequently found clinically. The clinical impact of LND is different between advanced-stage and early-stage tumors. Our study confirms this data: 0.031 is much lower than those showed in Table 7 .
In this study, we are the first to evaluate the value of LND in early-stage tongue cancer. Patients with LND .0.031 have significantly reduced OS, DSS, and DFS. This variable still remained significant for multivariate analysis in OS and DSS (Tables 4 and 5 ). In contrast, the conventional nodal staging system is inferior to LND in predicting OS, DSS, and DFS in current series noted by multivariate analysis.
In recent years, studies investigating the clinical significance of NLR in HNSCC have increased. It is believed that the white blood cell differential in HNSCC tends toward either a myeloid or a lymphoid lineage. The lymphoid preponderance was associated with better disease outcomes based on previous studies. Several studies found that higher NLR predicted reduced disease-specific survival and OS in HNSCC (Table 8) . [13] [14] [15] [16] [17] [18] The prognostic value of NLR between early-stage and advanced-stage oral cancer is different. An NLR .1.9 in advanced oral cancer showed reduced DSS 15 in our data, but 2.95 was much higher in the prognostic value of early-stage tongue cancer. In addition, the relationship between NLR and subsites of HNSCC was not thoroughly evaluated. 
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Prognostic value of nlr in early oral cancer Abbreviations: DFS, disease-free survival; DSS, disease-specific survival; ENE, extranodal extension; lnD, lymph node density; lVi, lymphovascular invasion; nlr, neutrophil-to-lymphocyte ratio; Os, overall survival; Pni, perineural invasion. Abbreviations: lnD, lymph node density; nlr, neutrophil-to-lymphocyte ratio.
Our result is comparable to these findings, showing that a high NLR is a poor prognostic factor in early-stage (cT1/T2N0) tongue cancer, although the cutoff value is different from that in previous studies. In our study, patients with NLR .2.95 have significantly reduced OS, DSS, and DFS that still remained significant on multivariate analysis (Tables 4-6 ). Interestingly, in our study, patients with NLR $2.95 correlated significantly with positive N classification, T2 classification, positive PNI, and a tumor thickness of .5 mm. This means that patients with NLR $2.95 in early-stage (cT1/T2N0) tongue cancer show more aggressive tumor behavior, leading to dismal prognosis. This is a novel finding about the relationship between NLR and the pathological adverse features in oral cancer.
The possible mechanism of tumor aggressiveness may come from the inflammation itself, which contributes to cancer initiation and progression. The inflammatory microenvironment would induce genotoxic stress via multiple mechanisms, including reactive oxygen species and induction of activation-induced cytidine deaminase. 
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Prognostic value of nlr in early oral cancer Abbreviations: DFS, disease-free survival; DSS, disease-specific survival; HNSCC, head and neck squamous cell carcinoma; LRRFS, local/regional relapse-free survival; MFS, metastatic-free survival; nlr, neutrophil-to-lymphocyte ratio; Os, overall survival; PFs, progression free survival.
from smoking is clear. In mice, smoking causes chronic inflammation by activating the nuclear factor-kappa B and mitogen-activated protein kinase pathways, consequently contributing to the formation of lung cancer. 37 Another example, circulating CD105, is recognized as a specific marker in ongoing angiogenesis related to tumor growth, and its expression was found to be elevated in inflammatory tissue. In our previous study, we proved that higher circulating CD105 promotes malignancy of cancer cells in oral cancer. 38 Importantly, in cancer patients, the neutrophil and/or lymphocyte counts forming NLR could be influenced by comorbid diseases, such as chronic inflammatory and autoimmune diseases, and by the intake of medications for immunodeficiency diseases, such as glucocorticosteroids and anti-inflammatory drugs. It is necessary to take notice of the above conditions before using NLR clinically.
Conclusion
Patients with early-stage (cT1/T2N0) tongue cancer and with NLR $2.95 show greater chance of aggressive clinicopathological adverse features, such as larger tumors, perineural invasion, and positive neck metastasis, leading to a reduced survival rate. If the NLR $2.95 in early-stage (cT1/T2N0) tongue cancer is noted, it should be treated as a very invasive tumor, and treatment should include elective neck dissection.
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